Literature DB >> 7931398

Wilson's disease: neurological and magnetic resonance imaging improvement on zinc treatment.

J M Heckmann, R W Eastman, J C De Villiers, R Hewlett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7931398      PMCID： PMC485505          DOI： 10.1136/jnnp.57.10.1273

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Cranial MRI in Wilson's disease.

Authors:  L Prayer; D Wimberger; J Kramer; G Grimm; W Oder; H Imhof
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

2.  Magnetic resonance imaging of the brain in Wilson's disease.

Authors:  K A Thuomas; S M Aquilonius; K Bergström; K Westermark
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

3.  Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine.

Authors:  C Veen; C J van den Hamer; P W de Leeuw
Journal:  J Intern Med       Date:  1991-06       Impact factor: 8.989

4.  Magnetic resonance imaging of the brain in Wilson's disease.

Authors:  H Nazer; J Brismar; M Z al-Kawi; T S Gunasekaran; K H Jorulf
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804
  4 in total
  3 in total

1.  Lenticular nucleus hyperechogenicity in Wilson's disease reflects local copper, but not iron accumulation.

Authors:  Uwe Walter; Marta Skowrońska; Tomasz Litwin; Grażyna Maria Szpak; Katarzyna Jabłonka-Salach; David Skoloudík; Ewa Bulska; Anna Członkowska
Journal:  J Neural Transm (Vienna)       Date:  2014-03-11       Impact factor: 3.575

2.  Reversible lesions in the brain parenchyma in Wilson's disease confirmed by magnetic resonance imaging: earlier administration of chelating therapy can reduce the damage to the brain.

Authors:  Duško B Kozić; Igor Petrović; Marina Svetel; Tatjana Pekmezović; Aleksandar Ragaji; Vladimir S Kostić
Journal:  Neural Regen Res       Date:  2014-11-01       Impact factor: 5.135

3.  Occupancy of the Zinc-binding Site by Transition Metals Decreases the Substrate Affinity of the Human Dopamine Transporter by an Allosteric Mechanism.

Authors:  Yang Li; Felix P Mayer; Peter S Hasenhuetl; Verena Burtscher; Klaus Schicker; Harald H Sitte; Michael Freissmuth; Walter Sandtner
Journal:  J Biol Chem       Date:  2017-01-17       Impact factor: 5.486
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.